Clinical Trials
9 trialsNCT03493789 2023-10-18
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
Emory University
Phase 1 Completed
NCT02448225 2022-10-19
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00450567 2020-08-03
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Jonsson Comprehensive Cancer Center
Completed
NCT00732563 2017-10-18
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Roswell Park Cancer Institute
Phase NA Completed
NCT00227539 2017-05-09
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
University of Washington
Phase 2 Completed
NCT00004138 2016-07-13
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT01172041 2016-07-01
The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging
Stanford University
Completed
NCT02481726 2015-06-25
68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
Xijing Hospital
Phase 1/2 Completed
NCT00002930 2013-01-18
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2/3 Completed